CSL Limited - Australian Company Profile

What does CSL Limited do?

CSL is a Public Company that generates the majority of its income from the Pharmaceutical Product Manufacturing industry.

In 2024 the company generated total revenue of $22,237,903,000 including sales and other revenue. In 2024 CSL had 32,000 employees including employees from all subsidiaries under the company's control.

The Chief Executive of CSL is Mr Paul McKenzie whose official title is Chief Executive Officer & Managing Director. The Chairman of CSL is Dr Brian McNamee whose official title is Independent Non-Executive Chairman.

CSL Limited develops and manufactures vaccines and plasma protein biotherapies. The company operates through four business units: CSL Behring - This unit is involved in the research, development, production and distribution of plasma-derived and recombinant products that are used to manufacture coagulation therapies to treat haemophilia, critical care products for shock in trauma treatment, immunoglobulins for infection treatment and autoimmune diseases. Plasma is also used in wound treatment therapies such as burn treatment. Human blood plasma is sourced from its collection centres and commercial purchases through CSL Plasma. Seqirus - This unit produces and distributes biotherapeutic products including influenza vaccines, prescription medicines, anti-venoms and in-licensed pharmaceuticals to treat and prevent serious human medical conditions. CSL Plasma - CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 300 plasma collection centers in U.S., Europe and China. Plasma collected at CSL Plasma facilities are used by CSL Behring for the purpose of manufacturing and delivering its therapies to people in more than 100 countries. CSL Vifor - Committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease. This is supported by its founding heritage and expertise in iron deficiency therapy, helping to support a broad range of patients in need.

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of CSL Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at CSL Limited by position type and title.

Enterprise Financials

Get a full view of CSL Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of CSL Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of CSL Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations CSL Limited operates in.

Competitor Benchmarking

Compare CSL Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Industries of Operation

Get an overview of the industries that BHP Group Limited operates in, including market share breakdowns and key industry insights.

Major Shareholders

We outline the ultimate parent and largest shareholders of CSL Limited.

Subsidiaries

View a list of CSL Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of CSL Limited, including founding information, past announcements, mergers and major projects.